SpeeDx receives FDA clearance for Mycoplasma genitalium product

SYDNEY, Australia, April 19, 2018 (GLOBE NEWSWIRE) — SpeeDx’s ResistancePlus® MG Positive Control kit has now been listed with the US Food and Drug Administration (FDA) for sale in the United States through the company’s recently incorporated US